⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11800863 | 0.82 | ALDH1A1 (0.52) | — | |
| SCHEMBL1729618 | 0.82 | APEX1 (0.42) | — | |
| SCHEMBL677187 | 0.81 | APEX1 (0.62) | — | |
| SCHEMBL6910658 | 0.80 | — | — | |
| SCHEMBL18180193 | 0.78 | APEX1 (0.77) | — | |
| SCHEMBL24439070 | 0.75 | ALDH1A1 (0.46) | — | |
| SCHEMBL7337432 | 0.75 | APEX1 (0.45) | — | |
| SCHEMBL24439301 | 0.72 | GRIA1 (0.46) | — | |
| SCHEMBL4184455 | 0.71 | APEX1 (0.47) | — | |
| SCHEMBL20967578 | 0.71 | APEX1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124274-A1 | METHODS OF INCREASING READTHROUGH OF A PREMATURE TERMINATION CODON | UNIV RAMOT (IL) | 2026-05-07 | — | — | US | claimed |
| US-20260027096-A1 | PHD INHIBITORS | UNIV OXFORD INNOVATION LTD (GB) | 2026-01-29 | — | — | US | claimed |
| EP-4655288-A1 | PHD INHIBITORS | Oxford University Innovation Limited (GB) | 2025-12-03 | — | — | EP | claimed |
| US-20250319119-A1 | COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS | MASSACHUSETTS GEN HOSPITAL (US) | 2025-10-16 | — | — | US | claimed |
| EP-3936608-B1 | REPROGRAMMING CELLS | SCRIPPS RESEARCH INST (US) | 2025-05-07 | — | — | EP | claimed |
| US-20250066735-A1 | PREPARATION METHOD OF MESENCHYMAL STEM CELL (MSC) AND APPLICATION THEREOF IN KNEE PRODUCT | GUANGDONG CELL BIOTECHNOLOGY CO. LTD (CN) | 2025-02-27 | — | — | US | claimed |
| EP-4512819-A2 | COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS | The General Hospital Corporation (US) | 2025-02-26 | — | — | EP | claimed |
| CN-118497122-B | Preparation method of mesenchymal stem cells and application of mesenchymal stem cells in knee joint products | 广东赛尔生物科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118497122-A | Preparation method of mesenchymal stem cells and application of mesenchymal stem cells in knee joint products | 广东赛尔生物科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| WO-2024157019-A1 | PHD INHIBITORS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2024-08-02 | — | — | WO | claimed |
| WO-2008155556-A1 | A METHOD FOR ASSAYING FTO (2-OXOGLUTARATE DEPENDENT OXYGENASE) ACTIVITY | ISIS INNOVATION LIMITED (GB) | 2008-12-24 | — | — | WO | claimed |
| EP-1929035-A1 | MINA53 ASSAYS | ISIS INNOVATION LIMITED (GB) | 2008-06-11 | — | — | EP | claimed |
| EP-1912637-A2 | INHIBITORS OF EGLN3 ACTIVITY FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2008-04-23 | — | — | EP | claimed |
| WO-2007034214-A1 | MINA53 ASSAYS | ISIS INNOVATION LIMITED (GB) | 2007-03-29 | — | — | WO | claimed |
| WO-2007009044-A2 | INHIBITORS OF EGLN3 ACTIVITY FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | DANA FARBER CANCER INSTITUTE, INC. (US) | 2007-01-18 | — | — | WO | claimed |
| EP-1451341-A4 | EIT-6, A POLYPEPTIDE ENCODED BY AN ESTROGEN REGULATED GENE | DANA FARBER CANCER INST INC (US) | 2005-07-13 | — | — | EP | claimed |
| US-20040248139-A1 | Eit-6, a polypeptide encoded by an estrogen regulated gene | DANA-FARBER CANCER INSTITUTE, INC. | 2004-12-09 | — | — | US | claimed |
| EP-1451341-A2 | EIT-6, A POLYPEPTIDE ENCODED BY AN ESTROGEN REGULATED GENE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2004-09-01 | — | — | EP | claimed |
| WO-2004058252-A2 | ANTI-CANCER AGENTS COMPRISING ALKB INHIBITORS AND ALKYLATING AGENTS | ISIS INNOVATION LIMITED (GB) | 2004-07-15 | — | — | WO | claimed |
| WO-2003042363-A2 | EIT-6, A POLYPEPTIDE ENCODED BY AN ESTROGEN REGULATED GENE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2003-05-22 | — | — | WO | claimed |